This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Myelin debris uptake by macrophages and microglia: Resolution of foam cells with a series of novel cyclodextrins.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
Sphingolipid-neutralizing molecular therapy reduces psychosine cytotoxicity in Krabbe disease.
iScience · 2026
Synthesis and Characterization of Cholesterol-Based Liquid Crystals Linked with Perfluorinated Alkyl Chains.
Molecules (Basel, Switzerland) · 2025 · senior author
Latest funding
- $1,132,200
Identifying and countering undesirable extracellular matrix components in lesions of multiple sclerosis
CIHR · 2025 · Co-investigator
- $36,000
Combating Multidrug Resistence: New Chemical Strategies to Target Bacterial Virulence Factors
NSERC · 2024 · Principal investigator
- $50,000
COVID-19 Variant Supplement - Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19
CIHR · 2021 · Co-investigator
58 publications.
Myelin debris uptake by macrophages and microglia: Resolution of foam cells with a series of novel cyclodextrins.
Wuerch EC, Baaklini CS, Zhang P, Mørch MT, Che A, D'Mello C, Ling CC, Yong VW
Sphingolipid-neutralizing molecular therapy reduces psychosine cytotoxicity in Krabbe disease.
Begum S, Hsueh SC, Cheria EMY, Espejo J, Zhang P, Collin A, Kappauf E, Mardenli M, Gelb MH, Ling CC, Maegawa GHB
Synthesis and Characterization of Cholesterol-Based Liquid Crystals Linked with Perfluorinated Alkyl Chains.
Che A, Zellmann-Parrotta CO, Ghaseminezhad H, Duong J, Williams VE, Ling CC
A Comprehensive Study of the Cobalt(II) Chelation Mechanism by an Iminodiacetate-Decorated Disaccharide Ligand.
Barbot C, Gouriou L, Mignot M, Sebban M, Zhang P, Landy D, Ling CC, Gouhier G
Cyclodextrin-based liquid crystals: A novel approach to promote the formation of thermotropic cubic mesophases and their potential applications as electrolytes.
Che A, Zellmann-Parrotta CO, Sarkar D, Espejo J, Michaelis VK, Sutherland TC, Williams VE, Ling CC
Targeting extracellular matrix components to attenuate microglia neuroinflammation: A study of fibulin-2 and CSPGs in a model of multiple sclerosis.
Randhawa G, Mobarakabadi M, D'Mello C, Morch MT, Zhang P, Ling CC, Yong VW, Ghorbani S
Editorial: Engineering antibodies and bacteriophages to manage and diagnose microbial infections.
Tanha J, Ng KKS, Ling CC
Therapeutic reduction of neurocan in murine intracerebral hemorrhage lesions promotes oligodendrogenesis and functional recovery.
Li H, Ghorbani S, Oladosu O, Zhang P, Visser F, Dunn J, Zhang Y, Ling CC, Yong VW, Xue M
Unprecedented Cubic Mesomorphic Behaviour of Crown-Ether Functionalized Amphiphilic Cyclodextrins.
Espejo J, Zellmann-Parrotta CO, Sarkar D, Che A, Michaelis VK, Williams VE, Ling CC
Synthesis and Mesomorphic Properties of Geometric and Conformation-Modulated Amphiphilic β-Cyclodextrin Liquid Crystals.
Che A, Ghaseminezhad H, Zellmann-Parrotta CO, Duong J, Williams VE, Ling CC
Identifying and countering undesirable extracellular matrix components in lesions of multiple sclerosis
Principal investigators: Yong, Voon W
Keywords: Axonal Injury; Cspgs; Extracellular Matrix; Microglia; Neurodegeneration; Neuroprotection; Oligodendrocyte; Proteoglycans; Remyelination; Translational Medicine
Combating Multidrug Resistence: New Chemical Strategies to Target Bacterial Virulence Factors
Principal investigators: Ling, Chang-Chun
Keywords: organic synthesis; synthetic methodology; carbohydrate chemistry; glycosylations; chemoenzymatic synthesis; bacterial surface glycans; bacterial adhesins; self-assembled systems; characterization of drug delivery systems; antibacterial strategies
COVID-19 Variant Supplement - Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19
Principal investigators: Ng, Kenneth K
Keywords: Antiviral Therapeutics; Enzyme Assay; Enzyme Inhibitors; Medicinal Chemistry; Organic Synthesis; Rna Polymerase; Structure-Based Drug Design; X-Ray Crystallography
Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19
Principal investigators: Ng, Kenneth K
Keywords: Antiviral Therapeutics; Enzyme Assay; Enzyme Inhibitors; Medicinal Chemistry; Organic Synthesis; Rna Polymerase; Structure-Based Drug Design; X-Ray Crystallography
Harnessing neuroinflammation to develop new treatments for multiple sclerosis and glioblastoma
Principal investigators: Yong, Voon W
Keywords: Chondroitin Sulfate Proteoglycans; Extracellular Matrix; Glioblastoma; Innate Immunity; Leukocyte Trafficking; Multiple Sclerosis; Neuroimmunology; Phase I/Iia Clinical Trial; Remyelination; Translational Medicine
The Development of Efficient Synthesis of Bacterial Nonulosonic Acids for immunological Studies
Principal investigators: Ling, Chang-Chun
A new therapeutic target in multiple sclerosis to attenuate neuroinflammation and neuropathology: the chondroitin sulfate proteoglycans
Principal investigators: Yong, Voon W
Keywords: Chemical Synthesis; Chondroitin Sulfate Proteoglycans; Experimental Autoimmune Encephalomyelitis; Extracellular Matrix; Inflammatory Perivascular Cuffs; Inhibitors; Multiple Sclerosis; Neuroimmunology; Neuropathology
Departmental Powder X-ray Diffractometer
Principal investigators: Trudel, Simon
Synthesis of Bioactive Oligosaccharides and Glycoconjugates to Elicit Carbohydrate-Specific Immune Responses and Enhance Molecular Recognitions
Principal investigators: Ling, ChangChun
Synthesis of glycoconjugates to elicit carbohydrate-specific immune responses and enhance molecular recognitions
Principal investigators: Ling, ChangChun
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Ratmir Derda and Chang-Chun Ling: 2 shared papers
- Matthias Amrein and Chang-Chun Ling: 2 shared papers
- Serge Rivest and Chang-Chun Ling: 1 shared paper
- Soheila Karimi-Abdolrezaee and Chang-Chun Ling: 1 shared paper
- Jeff Dunn and Yunyan Zhang: 1 shared paper
- Jeff Dunn and Chang-Chun Ling: 1 shared paper
- Yan Shi and Elmar Prenner: 1 shared paper
- Yan Shi and Chang-Chun Ling: 1 shared paper
- Yunyan Zhang and Chang-Chun Ling: 1 shared paper
- Matthias Amrein and Elmar Prenner: 1 shared paper
- Boguslaw Tomanek and Chang-Chun Ling: 1 shared paper
- Boguslaw Tomanek and Simon Trudel: 1 shared paper
- Farideh Jalilehvand and Chang-Chun Ling: 1 shared paper
- Elmar Prenner and Chang-Chun Ling: 1 shared paper
- Chang-Chun Ling and Simon Trudel: 1 shared paper
- Chemistry
- Cell Biology and Anatomy
- chemistry
- Oncology
- Biological Sciences
- Radiology
- Molecular Medicine
- Other
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Matthias Amrein
Cell Biology and Anatomy
2 shared papers, latest 2018
Ratmir Derda
chemistry
2 shared papers, latest 2021
Simon Trudel
Chemistry
1 shared papers, latest 2019
Jeff Dunn
Radiology
1 shared papers, latest 2025
Yan Shi
Microbiology and Infectious Diseases
1 shared papers, latest 2008
Yunyan Zhang
Department of Radiology
1 shared papers, latest 2025
Boguslaw Tomanek
Oncology
1 shared papers, latest 2019
Farideh Jalilehvand
Chemistry
1 shared papers, latest 2023
Serge Rivest
Molecular Medicine
1 shared papers, latest 2018
Elmar Prenner
Biological Sciences
1 shared papers, latest 2018
Soheila Karimi-Abdolrezaee
Physiology and Pathophysiology
1 shared papers, latest 2022
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.